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Abstract 
OBJECTIVE: The purpose of providing and maintaining a proper metabolic control is to prevent the development 
of chronic complications. In this study, we aimed to determine the influence of flexible insulin dosing with 
carbohydrate counting method on metabolic and clinical parameters in type 1 diabetes patients. 
MATERIAL AND METHODS: This study was conducted with patients following up at the Endocrinology Clinic 
with a diagnosis of type 1 diabetes mellitus between 2012 and 2015. Metabolic and clinical parameters before and 
after carbohydrate counting were compared. 
RESULTS: Forty patients were included in the study. Of the patients, 40% (n = 16) were female, and 60% (n = 
24) were male, and mean age was 21.5 ± 7 year at the time of diagnosis. Statistically significant differences were 
not detected when haemoglobin A1c, fasting plasma glucose, post-prandial glucose, LDL-cholesterol, and HDL-
cholesterol levels were compared at standard dose insulin use and after carbohydrate counting (P < 0.005). 
Among the parameters measured when the patients received standard dose of insulin without counting 
carbohydrate and flexible insulin dosing by counting carbohydrate, statistically, significant differences were not 
detected for baseline insulin dose, bolus insulin dose, triglyceride level, body mass index, or monthly 
hypoglycemia episodes (P > 0.05). 
CONCLUSION: Flexible insulin dosing with carbohydrate counting provides significant improvements in clinical 
and metabolic control. We detected improvements in lipid profiles and glycemic control. Additionally, patients 
generally did not gain weight despite flexible nutrition, and frequency of hypoglycemia remained unchanged 
despite strict glycemic control. 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Diabetes mellitus is a critical health problem. 
Its prevalence is gradually increasing, leading to 
higher morbidity and mortality. Approximately 5 to 
10% of diabetic patients have type 1 DM [1]. Diabetes 
prevalence has been determined to range from 7.2 to 
11.4% worldwide according to data from the 
International Diabetes Federation. In Turkey, the 
prevalence of diabetes among individuals 20 years 
and above is 13.7% [2]. 
The goal of providing and maintaining proper 
metabolic control is to prevent the development of 
chronic complications. Various treatment methods 
have been investigated for this purpose [1] [2] [3]. 
Reducing HbA1c levels through effective insulin 
treatment was shown to reduce the risk of 
microvascular complications of diabetes. 
Carbohydrate counting enables diabetic patients to 
pursue flexible nutrition and flexible insulin dosing [4]. 
In this study, we aimed to investigate the influence of 
flexible insulin dosing with carbohydrate counting 
method on metabolic and clinical parameters in type 1 
diabetes patients. 
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Material and Methods 
 
This study was conducted with 40 patients 
who are presented at the Endocrinology Clinic with a 
diagnosis of type 1 diabetes mellitus between 2012 
and 2015. Definition of type 1 DM followed the criteria 
defined by the World Health Organization. Subjects 
were evaluated regarding age, gender, clinical signs 
and symptoms at the time of diagnosis, duration of 
symptoms, and blood and urine biochemistry. 
Glycosylated haemoglobin concentrations (HB A1c%) 
were measured using the tribometric inhibition 
immunoassay method with a Cobas Integra analyser. 
Biochemical tests-fasting plasma glucose, 
postprandial plasma glucose, total cholesterol, 
triglyceride, LDL-cholesterol, HDL-cholesterol levels 
were measured using an Olympus AU600 (Olympus 
Optical Co. Ltd., Japan) auto-analyser following 
manufacturer instructions. 
Patients who participated in the study 
completed three stages of carbohydrate counting. The 
patients who have been using flexible insulin dosing 
with carbohydrate counting were doing this for 6 to 24 
months. A total of 56 patients with type 1 DM younger 
than 18 years were assessed for eligibility in the 
study, or those who were pregnant (n = 4), lactating (n 
= 2), or unaware of carbohydrate counting (n = 6) and 
had not completed all three stages of carbohydrate 
counting (n = 4) were excluded from the study. Body 
composition was determined using Tanita BC-418 via 
height, weight, bioelectric impedance analysis, and 
body mass index (BMI) calculations. Data about 
insulin dosing before carbohydrate counting, 
hypoglycemic event count, biochemical and metabolic 
parameters were obtained from patient files. Those 
patients who had missing data were not included in 
the study. 
Subjects were compared regarding metabolic 
and biochemical parameters before and after 
carbohydrate counting. 
All data are given as mean±standard 
deviation (SD). Statistical analyses were done with 
SPSS 16.0 (SPSS Inc., Chicago, IL). Correlation 
analyses were performed using Pearson correlation 
analysis. Statistical analyses of averages were done 
using independent paired t-test and Wilcoxon test. A p 
level of < 0.05 was accepted as statistically significant. 
 
 
Results 
 
A total of 40 patients completed the study. Of 
the patients, 40% (n = 16) were female, 60% (n = 24) 
were male. Mean age was 21.5 ± 7 years at the time 
of diagnosis. A statistically significant difference was 
not detected between groups regarding gender 
distribution (P > 0.05). Socio-demographic 
characteristics of the subjects are shown in Table 1. 
Clinical and laboratory outcomes of the patients when 
using standard insulin dosing and flexible insulin 
dosing with carbohydrate counting are shown in Table 
2. 
Table 1: Socio-demographic characteristics of the patients 
Parameters  
Age (year), median
 
21.5 ± 7 
Body mass index (BMI, kg/m
2
) 22 
Diabetes age (year) 12.8 ± 9.1 
Gender (M/F) n:24.60%/n:16.40% 
Duration of carbohydrate counting (month) median 18.4 (6-24) 
 
 
Median haemoglobin A1c values with 
standard insulin dosing and flexible insulin dosing 
were 8.0% and 7.30%, respectively (P = 0.007). 
Fasting plasma glucose was found to be 165.90 mg/dl 
before carbohydrate counting and 140.70 mg/dl after 
carbohydrate counting (P = 0.049).  
Table 2: Clinical and laboratory outcomes of the patients when 
using standard insulin dosing before carbohydrate counting 
and when using flexible insulin dosing according to 
carbohydrate counting 
 
Parameters 
Standard insulin 
dosing before 
carbohydrate counting 
Flexible insulin 
dosing according to 
carbohydrate 
counting 
 
P value 
BMI (kg/m
2
) 22 22 0.121 
Hemoglobin A1c (%) 8.1 7,3 0.007 
Fasting plasma glucose (mg/dL) 165.9  140.7 0.049 
Post-prandial glucose (mg/dL) 241.1 149.43 0.001 
Triglyceride (mg/dL) 85 94 0.863 
HDL-cholesterol (mg/dL) 55.5 66.5 0.039 
LDL-cholesterol (mg/dL) 85.5 78.5 0.036 
Hypoglycemia (episodes/month) 4 4 0.124 
Total insulin dose (IU/day) 38.5 37 0.738 
Basal dose (IU/day) 16 20 0.056 
Bolus dose (IU/day) 19 18 0.224 
 
Post-prandial plasma glucose was 241.10 
mg/dl before carbohydrate counting and 149.43 mg/dl 
after carbohydrate counting (P = 0.001). LDL-
cholesterol level was detected to be 85.50 mg/dl when 
patients used a standard dose of insulin and 78.50 
mg/dl when they used flexible insulin dosing (P = 
0.036). HDL-cholesterol levels were 55.50 mg/dl 
before carbohydrate counting; they reached 65.50 
mg/dl with flexible insulin dosing (P = 0.038). 
However, a statistically significant difference was not 
detected between the periods before and after 
carbohydrate counting regarding basal insulin dose, 
bolus insulin dose, triglyceride level, body mass index, 
or monthly hypoglycemia episode count (P > 0.05). 
 
 
Discussion 
 
Very strict low carbohydrate intake was a 
method used to treat type 1 DM before the discovery 
of insulin. Lower glucose levels are obtained with a 
flexible dose of multiple insulin injections with 
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carbohydrate counting. Therefore; actual guidelines 
recommend intensive insulin treatment paired with a 
flexible diet [5]. The target of carbohydrate counting is 
to promote glycemic control by implementing a 
consistent pattern of carbohydrate consumption with 
meals and snacks from day to day. Since 
carbohydrate intake directly identify postprandial 
blood glucose, management of carbohydrate 
consumption and suitable insulin adjustments for 
identified amount of carbohydrate can improve 
glycemic control [6]. In our study, patients are 
applying short-acting insulin with carbohydrate 
counting for 18.4 (6-24) months. This method provides 
flexibility in carbohydrate intake. Many patients may 
not optimally follow this method due to the high 
carbohydrate content of foods or being unable to 
estimate the proper dose [7]. In follow-ups with our 
patients, they were seen to match short-acting insulin 
and carbohydrates according to fasting and post-
prandial plasma glucose. This may be explained by 
close monitoring of the patients and long-lasting 
education about carbohydrate counting. 
Studies are available indicating that 
carbohydrate-restricted diet may be a lifestyle option 
in patients wanting to lose weight. A carbohydrate-
restricted diet leads to weight loss in patients with type 
1 DM [8] [9]. Our patients did not have a change in 
weight when they used flexible insulin dosing with 
carbohydrate counting compared to a standard dose 
of insulin use with a conventional diet (P > 0.05). 
Some studies showed that the patients eating with 
carbohydrate counting had higher BMI compared to 
the patients eating a conventional diet [10]. These 
studies reported that intensive insulin treatment and a 
flexible eating plan might lead to an increase in BMI of 
patients with type 1 DM [11]. 
Studies have shown that the A1c level was 
lower in patients who used flexible insulin dosing with 
carbohydrate counting [12]. Prandial insulin dose was 
shown to lead to 1-1.5 units of a decrease in A1c 
value, as it is performed according to total insulin dose 
[13]. The appearance of chronic complications is 
delayed when glycemic control and A1c control are 
achieved with intensive insulin treatment. 
Complication development slows down between 30% 
and 75% [14] [15]. In our study, we detected that 
patients could achieve a better glycemic control when 
they used flexible insulin dosing with carbohydrate 
counting. We detected a 9.8% decrease in HbA1c 
value (P = 0.007), a 15% decrease in fasting plasma 
glucose (P = 0.049), and a 37.9% decrease in post-
prandial plasma glucose (P = 0.001). These 
differences are statistically significant. 
Hypertriglyceridemia correlated with 
hyperglycemia and low HDL-cholesterol is seen in 
patients with type 1 DM. This impaired lipid profile 
may improve with active insulin treatment [16]. 
Studies have shown that while triglyceride, HDL-
cholesterol decrease, LDL-cholesterol was shown to 
increase in patients using flexible insulin dosing [13]. 
In our study, triglyceride level was seen to increase 
11.7% (P = 0.863), HDL-cholesterol level was seen to 
increase 19.8% (P = 0.039), LDL-cholesterol level was 
seen to decrease 8.1% (P = 0.036) when treatment 
was switched to flexible eating, flexible insulin dosing 
from conventional eating. This lipid profile may be 
explained by better glycemic control through flexible 
eating and intensive, flexible insulin dosing. 
Studies have not detected a difference 
between patients who use flexible insulin dosing with 
carbohydrate counting and who use standard insulin 
dosing regarding insulin dose and hypoglycemia 
frequency [10] [11] [12] [13] [14] [15] [16]. Meta-
analysis could not be done due to inconsistency 
between hypoglycemia measurement and reporting; 
however, the frequency of hypoglycemia was 
estimated to decrease [17]. In our study, a statistically 
significant difference could not be detected about 
basal and bolus insulin dose or some hypoglycemic 
episodes when treatment was switched to flexible 
insulin dosing from standard insulin dosing (P > 0.05). 
Daily total insulin dose decreased by 3.8% (P = 
0.738), bolus insulin dose decreased by 5.2% (P = 
0.224), and basal insulin dose increased by 25% (P = 
0.056). Monthly median hypoglycemic episode count 
was equal in both conditions at 4 hypoglycemic 
episodes/month. HbA1c levels would be normal in all 
diabetic patients if hypoglycemia did not occur. 
Hypoglycemia limits long-term benefits of glycemic 
control in patients with type 1 DM [18] [19]. Flexible 
insulin dosing, carbohydrate counting, and flexible 
eating provide better glycemic control without 
increasing hypoglycemia risk in patients with type 1 
DM. 
In conclusion, flexible insulin dosing with 
carbohydrate counting provides a significant 
improvement in clinical and metabolic control. We 
detected that frequency of hypoglycemia did not 
change despite improvements in lipid profile, glycemic 
control, lack of weight gain despite flexible eating, and 
strict glycemic control. This method enables the 
patients to enjoy a more flexible life and is more 
sustainable. Patients should be provided with a more 
flexible lifestyle through better nutrition education and 
more active participation in the treatment of their 
diseases. 
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